BIONDVAX PHARMACEUTICALS LTD's ticker is BVXVW and the CUSIP is 09073Q113. A total of 4 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | +200.0% | 1,179 | -2.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 1,203 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 1,203 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 1,203 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 1,203 | -7.7% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 1,303 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 1,303 | -34.9% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 2,001 | -9.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 2,200 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 2,200 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 2,200 | +57.1% | 0.00% | – |
| Q4 2015 | $1,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 72,800 | $25,000 | 0.02% |
| UBS Group AG | 1,203 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,962 | $7,000 | 0.00% |